S

Syncom Formulations (India) Ltd
BSE:524470

Watchlist Manager
Syncom Formulations (India) Ltd
BSE:524470
Watchlist
Price: 11.88 INR -1% Market Closed
Market Cap: ₹11.2B

Operating Margin

11.1%
Current
Improving
by 0.8%
vs 3-y average of 10.3%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11.1%
=
Operating Income
₹552.2m
/
Revenue
₹5B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
11.1%
=
Operating Income
₹552.2m
/
Revenue
₹5B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Syncom Formulations (India) Ltd
NSE:SYNCOMF
11.5B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
954.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
546.2B USD
Loading...
CH
Roche Holding AG
SIX:ROG
268.4B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
209.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
219B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
265.4B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
147.6B USD
Loading...
FR
Sanofi SA
PAR:SAN
94.4B EUR
Loading...

Market Distribution

In line with most companies in India
Percentile
64th
Based on 5 437 companies
64th percentile
11.1%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Syncom Formulations (India) Ltd
Glance View

Market Cap
11.2B INR
Industry
Pharmaceuticals

Syncom Formulation India Ltd. is a pharmaceutical company, which engages in the development, manufacture, and marketing of healthcare products. The company is headquartered in Indore, Madhya Pradesh. The firm manufactures and markets more than 300 pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquid orals, liquid vials and ampoule injections and dry vial injections, dry syrups, ointments and inhalers. Its segments include Pharmaceuticals Drugs & Formulations, Trading of Commodities and Renting of property. Its product categories include tablets, capsules, ointments, injections, liquid-oral and packaging variants. The company offers various products, including generics, alpha adrenoceptor agonist, analgesic, antipyretic, anti-inflammatory, anti-ulcer agents, antibiotic, antidepressant, antiviral, cephelo sporins, cortico steroid, estrogen, cough suppressant and sedative anticonvulsant, among others. The firm operates in more than 15 countries across the world.

SYNCOMF Intrinsic Value
14.05 INR
Undervaluation 15%
Intrinsic Value
Price
S
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
11.1%
=
Operating Income
₹552.2m
/
Revenue
₹5B
What is Syncom Formulations (India) Ltd's current Operating Margin?

The current Operating Margin for Syncom Formulations (India) Ltd is 11.1%, which is above its 3-year median of 10.3%.

How has Operating Margin changed over time?

Over the last 2 years, Syncom Formulations (India) Ltd’s Operating Margin has increased from 8.4% to 11.1%. During this period, it reached a low of 8.4% on Aug 30, 2023 and a high of 11.8% on Mar 31, 2025.

Back to Top